MetLife Valuation Overview

MET -- USA Stock  

USD 39.76  0.88  2.26%

MetLife secures last-minute Real Value of $48.1925 per share. The latest price of the firm is $39.76. At this time the firm appears to be under valued. Macroaxis forecasts value of MetLife from analyzing the firm fundamentals such as Current Valuation of 114.15B, Profit Margin of 7.89% and Return On Equity of 9.90% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
Investments

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
MetLife Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

MetLife Market Cap

MetLife is regarded second in market capitalization category among related companies. Market capitalization of Insurance - Life industry is now estimated at about 172.24 Billion. MetLife totals roughly 39 Billion in market capitalization claiming about 23% of equities under Insurance - Life industry.
Capitalization  Workforce  Revenue  Total debt  Valuation
Horizon     30 Days    Login   to change
MetLife is regarded fifth in beta category among related companies. It is rated below average in price to book category among related companies fabricating about  0.64  of Price to Book per Beta. The ratio of Beta to Price to Book for MetLife is roughly  1.57 

Current Market Valuation

MetLife Valuation Boundaries

Under Valued
December 18, 2018
39.76
Market Value
48.19
Real Value
Target Odds
  
54.10
Upside
MetLife is not too volatile asset. Calculation of real value of MetLife is based on 2 months time horizon. Increasing MetLife time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Basics

MetLife Enterprise Value Fundamentals

Quick Ratio0.85
Revenue Growth0.80%
Payout Ratio32.67%
Enterprise Value To Ebitda17.03
Enterprise Value To Revenue1.68
Please see also Stocks Correlation. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Search macroaxis.com